Market Closed

XFOR
X4 Pharmaceuticals
$ 3.12
-1.58%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

X4 Pharmaceuticals News

Latest X4 Pharmaceuticals Stock News & XFOR Headlines

X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Tops Revenue Estimates
10 days ago | zacks.com
X4 Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
10 days ago | globenewswire.com
X4 Pharmaceuticals to Participate in Guggenheim, Stifel, and Jefferies Conferences in November 2026
11 days ago | globenewswire.com
X4 Pharmaceuticals, Inc. (XFOR) Analyst/Investor Day Transcript
16 days ago | seekingalpha.com
X4 Pharmaceuticals Highlights Clinical Progress and Market Opportunity for Mavorixafor in Primary Chronic Neutropenia During Virtual Investor Day
16 days ago | globenewswire.com
X4 Pharmaceuticals Targets 2028 Phase III Data for Mavorixafor in Chronic Neutropenia
16 days ago | marketbeat.com
X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
a month ago | globenewswire.com
X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
a month ago | globenewswire.com
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Stock Rated “Moderate Buy” by Sell-Side Brokerages
a month ago | defenseworld.net
Down 25.4% in 4 Weeks, Here's Why X4 Pharmaceuticals (XFOR) Looks Ripe for a Turnaround
2 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

XFOR
X4 Pharmaceuticals
$ 3.12
-1.58%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago